PRIMARY STUDY

Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease

Key Findings:  Data suggests that cannabis using patients did not demonstrate more frequent active disease or IBD-associated complications. As such, the authors posit that other non-luminal (organ cavity) factors influenced their symptoms and/or decision to use cannabis.

Type of Study:  Meta-analysis

Study Sample Size:  383

Study Result:  Inconclusive

Research Location(s):  United States

Year of Pub:  2021


Cannabinoids Studied:  Cannabinoid (unspecified)

Phytocannabinoid Source:  Unspecified




Citation:  Coates MD, et al. Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease. Cannabis Cannabinoid Res. 2022; 7:445-450. doi: 10.1089/can.2020.0155

Authors:  Coates MD, Dalessio S, Walter V, Stuart A, Bernasko N, Tinsley A, Razeghi S, Williams ED, Clarke K, Vrana K